Thursday, 2 December 2021
  
Login

Australia's most trusted
source of pharma news

Thursday, 02 December 2021
News

Bumper PBAC March agenda

Posted 25 November 2021 AM

In what is already shaping up to be a bumper 2022, PBAC has dropped a hefty agenda for its first meeting of the year with 35 new listings up for consideration in March.

Many of the medicines on the table are yet to be TGA approved, indicating these companies have submitted their new drugs via parallel processing and hint at new arrivals, potentially this year or by early 2022.

To see the whole article, please login

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.